Who
Philip Wagenheim
Director
Company insider
Files Form 4 as: Director and 10% owner, Swarmer; Director, Immunome; Secretary, The ONE Group Hospitality.
In numbers
- Trades disclosed
- 39
- Buys
- 4
- Sells
- 4
- Bought
- $461K
- Sold
- $2.7M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 27 May 2011
- Last trade
- 1 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | SWMR Swarmeroption or derivative · Software | SEC FORM 4 Code A | —6,428 at $0.00 | filing |
| 16 Sep 2026filed 17 Sep 2026 | SWMR SwarmerSoftware | SEC FORM 4 Code X | $2.7M819,487 at $3.33 | filing |
| 16 Sep 2026filed 17 Sep 2026 | SWMR Swarmeroption or derivative · Software | SEC FORM 4 Code X | —899,988 | filing |
| 16 Sep 2026filed 17 Sep 2026 | SWMR Swarmeroption or derivative · Software | SEC FORM 4 Code X | —899,988 | filing |
| 16 Sep 2026filed 17 Sep 2026 | SWMR SwarmerSoftware | SEC FORM 4 Code X | $2.7M819,487 at $3.33 | filing |
| 15 Sep 2026filed 17 Sep 2026 | SWMR SwarmerSoftware | SEC FORM 4 Code J | —1,124,981 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | SWMR SwarmerSoftware | SEC FORM 4 Code J | —1,124,981 at $0.00 | filing |
| 13 Aug 2026filed 17 Aug 2026 | SWMR Swarmeroption or derivative · Software | SEC FORM 4 Code A | —2,511 at $0.00 | filing |
| 13 Aug 2026filed 17 Aug 2026 | SWMR Swarmeroption or derivative · Software | SEC FORM 4 Code A | —2,511 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,897 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,897 at $0.00 | filing |
| 23 Mar 2026filed 23 Mar 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $582K28,200 at $20.65 | filing |
| 23 Mar 2026filed 23 Mar 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $582K28,200 at $20.65 | filing |
| 20 Mar 2026filed 23 Mar 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $753K36,800 at $20.47 | filing |
| 20 Mar 2026filed 23 Mar 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $753K36,800 at $20.47 | filing |
| 18 Mar 2026filed 18 Mar 2026 | SWMR SwarmerSoftware | SEC FORM 4 Code C | —1,124,981 | filing |
| 18 Mar 2026filed 18 Mar 2026 | SWMR Swarmeroption or derivative · Software | SEC FORM 4 Code C | —597,980 | filing |
| 18 Mar 2026filed 18 Mar 2026 | SWMR Swarmeroption or derivative · Software | SEC FORM 4 Code C | —597,980 | filing |
| 18 Mar 2026filed 18 Mar 2026 | SWMR SwarmerSoftware | SEC FORM 4 Code C | —1,124,981 | filing |
| 10 Jun 2025filed 12 Jun 2025 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,864 at $0.00 | filing |
News
Arbutus Biopharma (NASDAQ:ABUS) vs. Immunome (NASDAQ:IMNM) Financial ComparisonIMNM · themarketsdaily.com · 12 Oct 2026
0 headlines in the last 90 days name Philip Wagenheim; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.